Bacteremia Sepsis: Clinical Trials

11 trials for Bacteremia Sepsis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 recruiting, 2 active not recruiting, 1 terminated. 5 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 2, Recruiting 2, Active not recruiting 1
Phase 41Recruiting 1

Follow Bacteremia Sepsis: new trials by email Literature Review of Bacteremia Sepsis trials Research Report on Bacteremia Sepsis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oral Switch in Pediatric Bloodstream Infections
Oral antibiotic therapy, Standard IV antibiotic therapy - Bloodstream Infection, Bacteremia Sepsis
Phase 4RecruitingUlrikka Nygaard1502026-09-012026-10-19
Machine Learning Assisted Electrochemical Profiling to Provide Early Identification of Bloodstream Infections Pathogens
Blood culture sampling - Bacteremia Sepsis
Not applicableRecruitingUniversity Hospital, Grenoble2002026-07-132026-07-22
The Impact of Fast Antimicrobial Sensitivity Testing Tools on Stewardship Antibiotic and Clinical Outcome (ACT-FAST)
Diagnostic Test: Rapid Antimicrobial Susceptibility Testing (R-AST) guided Stewardship, Standard of Care (SOC) - Bloodstream Infection, Gram-Negative Infections
Not applicableRecruitingIstituto Clinico Humanitas4002026-03-192026-06-24
Initial Feasibility Study of the CycloPE® Device
PATH EX CycloPE® Device - Sepsis, Infection
Not applicableActive not recruitingPATH EX, Inc.152024-06-112025-05-14
Risk Factors of Post-ERCP Sepsis
exposure to hypotension during the Endoscopic Retrograde Cholangiopancreatography (ERCP) for obstructive jundice. - Sepsis, Intraoperative Hypotension
UnknownMansoura University1002023-12-232024-01-25
Resistell Phenotech AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia
Resistell Phenotech - Bacteremia Sepsis
TerminatedResistell AG2462023-01-182024-10-26
Monocyte Distribution Width (MDW) in the General Population of Emergency Department Patients With and Without Bacteremia
Monocyte Distribution Width (MDW) , observation - Bacteremia, Bacteremia Sepsis
Active not recruitingHenry Ford Health System500002021-07-012026-05-12
Nanomotion-based Resistell AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia and/or Sepsis
Resistell AST - Bacteremia Sepsis
CompletedResistell AG3002021-06-182024-04-10
Clinical and Medico-economic Evaluation of a Rapid Test (ePlex-BCID®, GenMark) for the Diagnosis of Bacteremia and Fungemia.
Multiplex PCR, Current strategy alone - Bacteremia Sepsis, Fungemia
Not applicableCompletedUniversity Hospital, Grenoble3122019-06-202021-11-03
Effect of dRAST on Treatment for Bacteremia in Patients With Hematologic Diseases
dRAST, Current standard method - Hematologic Diseases, Bacteremia Sepsis
Not applicableCompletedSeoul National University Hospital1162018-09-012019-10-14
Prevalence and Characterization of Diagnostic Error Among Patients With Bacteremia
Bacteremia Sepsis
CompletedAimee Li15702016-01-012018-07-06

Narrower conditions

Sepsis (6)  ·  Bacteremia (5)  ·  Disease Susceptibility (1)  ·  Emergencies (1)  ·  Escherichia coli Infections (1)  ·  Fungemia (1)  ·  Hematologic Diseases (1)  ·  Infections (1)  ·  Shock, Septic (1)  ·  Systemic Inflammatory Response Syndrome (1)

Broader conditions

Pathologic Processes (10)  ·  Pathological Conditions, Signs and Symptoms (10)  ·  Infections (9)  ·  Inflammation (9)  ·  Systemic Inflammatory Response Syndrome (8)  ·  Bacterial Infections and Mycoses (7)  ·  Bacterial Infections (6)  ·  Sepsis (3)  ·  Disease Attributes (2)  ·  Shock (2)  ·  Enterobacteriaceae Infections (1)  ·  Gram-Negative Bacterial Infections (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Invasive Fungal Infections (1)  ·  Mycoses (1)

Interventions

Anti-Infective Agents (1)  ·  Cholangiopancreatography, Endoscopic Retrograde (1)

Sponsors

Resistell AG (2)  ·  University Hospital, Grenoble (2)  ·  Aimee Li (1)  ·  Henry Ford Health System (1)  ·  Istituto Clinico Humanitas (1)  ·  Mansoura University (1)  ·  PATH EX, Inc. (1)  ·  Seoul National University Hospital (1)  ·  Ulrikka Nygaard (1)

Countries

France (2)  ·  Switzerland (2)  ·  Armenia (1)  ·  Austria (1)  ·  Denmark (1)  ·  Egypt (1)  ·  Italy (1)  ·  South Korea (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Anja K Jaehne, MD (1)  ·  Harutyun N Mangoyan, MD. PhD (1)  ·  Moataz M Emara, MD, EDAIC (1)  ·  Ulrikka Nygaard, MD, PhD, DMSc (1)

Results publications

PMID 36410804, PMID 38499536, PMID 41173335